Suppr超能文献

血清来源的牛免疫球蛋白/蛋白质分离物在健康成年人中的吸收及安全性

Absorption and safety of serum-derived bovine immunoglobulin/protein isolate in healthy adults.

作者信息

Shaw Audrey L, Mathews David W, Hinkle John E, Petschow Bryon W, Weaver Eric M, Detzel Christopher J, Klein Gerald L, Bradshaw Timothy P

机构信息

Clinical Development, Entera Health, Inc.

Life Sciences Consulting and Analytics, EarlyPhase Sciences, Inc., Cary.

出版信息

Clin Exp Gastroenterol. 2016 Dec 5;9:365-375. doi: 10.2147/CEG.S120118. eCollection 2016.

Abstract

PURPOSE

Previous studies have shown that oral administration of bovine immunoglobulin protein preparations is safe and provides nutritional and intestinal health benefits. The purpose of this study was to evaluate the plasma amino acid response following a single dose of serum-derived bovine immunoglobulin/protein isolate (SBI) and whether bovine immunoglobulin G (IgG) is present in stool or in blood following multiple doses of SBI in healthy volunteers.

METHODS

A total of 42 healthy adults were administered a single dose of placebo or SBI at one of three doses (5 g, 10 g, or 20 g) in blinded fashion and then continued on SBI (2.5 g, 5 g, or 10 g) twice daily (BID) for an additional 2 weeks. Serial blood samples were collected for amino acid analysis following a single dose of placebo or SBI. Stool and blood samples were collected to assess bovine IgG levels.

RESULTS

The area under the curve from time 0 minute to 180 minutes for essential and total amino acids as well as tryptophan increased following ingestion of 5 g, 10 g, or 20 g of SBI, with a significant difference between placebo and all doses of SBI (<0.05) for essential amino acids and tryptophan but only the 10 g and 20 g doses for total amino acids. Bovine IgG was detected in the stool following multiple doses of SBI. No quantifiable levels of bovine IgG were determined in plasma samples 90 minutes following administration of a single dose or multiple doses of SBI.

CONCLUSION

Oral administration of SBI leads to increases in plasma essential amino acids during transit through the gastrointestinal tract and is safe at levels as high as 20 g/day.

摘要

目的

先前的研究表明,口服牛免疫球蛋白蛋白制剂是安全的,且具有营养和肠道健康益处。本研究的目的是评估单次服用血清来源的牛免疫球蛋白/蛋白分离物(SBI)后血浆氨基酸的反应,以及在健康志愿者多次服用SBI后粪便或血液中是否存在牛免疫球蛋白G(IgG)。

方法

总共42名健康成年人以盲法接受单次剂量的安慰剂或三种剂量(5克、10克或20克)之一的SBI,然后继续每日两次(BID)服用SBI(2.5克、5克或10克),持续另外2周。在单次服用安慰剂或SBI后采集系列血样进行氨基酸分析。采集粪便和血样以评估牛IgG水平。

结果

摄入5克、10克或20克SBI后,必需氨基酸、总氨基酸以及色氨酸从0分钟到180分钟的曲线下面积增加,对于必需氨基酸和色氨酸,安慰剂与所有剂量的SBI之间存在显著差异(<0.05),但对于总氨基酸仅10克和20克剂量存在显著差异。多次服用SBI后在粪便中检测到牛IgG。在单次或多次服用SBI后90分钟的血浆样本中未测定到可量化水平的牛IgG。

结论

口服SBI会导致胃肠道转运过程中血浆必需氨基酸增加,且高达20克/天的剂量是安全的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba24/5147394/f6c6dd8e8461/ceg-9-365Fig1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验